ClinicalTrials.gov record
Completed Phase 1 Interventional

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

ClinicalTrials.gov ID: NCT00089427

Public ClinicalTrials.gov record NCT00089427. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 12:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I Study of Convection Enhanced Delivery (CED) of IL13-PE38QQR Infusion After Resection Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma

Study identification

NCT ID
NCT00089427
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
INSYS Therapeutics Inc
Industry
Enrollment
24 participants

Conditions and interventions

Interventions

  • IL13-PE38QQR Drug
  • Radiation therapy Procedure
  • Surgery for placement Procedure
  • Temozolomide with radiation therapy Drug

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2004
Primary completion
Jun 30, 2007
Completion
Not listed
Last update posted
Jul 3, 2011

Started 2004

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
University of California San Francisco - Dept. of Neurological Surgery San Francisco California 94143
Carolina Neurosurgery & Spine Assoc. Charlotte North Carolina 28204
Duke University Medical Center Durham North Carolina 27710
Cleveland Clinic Foundation Department of Neurological Surgery Cleveland Ohio 44195
University of Texas M.D. Anderson Cancer Center Houston Texas 77030
University of Virginia Health Systems - Department of Neurological Surgery Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00089427, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 3, 2011 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00089427 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →